Search International and National Patent Collections
|1. (WO2018056361) NOVEL ALKYLATING AGENT|
|Title:||NOVEL ALKYLATING AGENT|
The purpose of the present invention is to provide a novel alkylating agent that binds specifically to immune checkpoint genes, that induces cell death, and that has a tumor-specific aggregating property. Provided are: a complex which specifically binds to genes that encode immune checkpoint molecules, and which includes an alkylating agent bonded to a polyamide; an alkylating agent that includes the complex, and that is specific to genes encoding immune checkpoint molecules; and a pharmaceutical composition including the complex.